Press Release: ParaZero Announces First Half of 2025 Financial Results

Dow Jones
08/29

KFAR SABA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, reported today its financial results for the six months ended June 30, 2025.

Key Highlights of ParaZero's Achievements in the First Half of 2025 & Recent Updates:

Financial and Corporate Updates:

   -- Sales increased by 26.6% to $357,979 for the six months ended June 30, 
      2025. 
 
   -- ParaZero raised approximately $3.1 million and $2.2 million in gross 
      proceeds from registered direct offerings in February 2025 and August 
      2025, respectively 
 
   -- Appointed Ariel Alon, a senior UAV executive, as company's CEO. 

Counter-Drone Systems:

   -- ParaZero bolstered its counter-drone technology with approval from the 
      Israeli Defense Export Controls Agency $(DECA)$ under the Israeli Ministry 
      of Defense approval to market DefendAir globally, targeting a high-growth 
      market. 
 
   -- Showcased DefendAir Hand-Held Net Launcher in two field tests with a 
      select group of Israeli security and defense professionals, each 
      demonstrating a 100% interception success rate, effectively neutralizing 
      every fast-incoming multirotor drone threat in real-time scenarios. 
 
   -- Conducted several field trials of updated configurations to provide 
      solutions to different evolving drone threat scenarios, at the discretion 
      of defense entities, which further strengthened its market position. The 
      company quickly reshaped its strategy, technology, and IP assets to 
      address one of the world's biggest commercial, homeland security, and 
      defense challenges: the threats posed by drones. 

Airdrop Systems:

   -- Enhanced its portfolio with successful DropAir precise airdrop system 
      tests for critical supply delivery. Integrated with military and several 
      commercial drones, DropAir enabled rapid autonomous and accurate supply 
      through drones in the most challenging terrains in general, and the 
      supplement of blood transfusions in combat specifically, as shown in a 
      defense demo. 
 
   -- Progressed to Phase II with the Israeli Ministry of Defense, focusing on 
      delivering pilot systems for implementation and additional operational 
      testing in various scenarios. 
 
   -- Secured global marketing approvals from DECA under the Israeli Ministry 
      of Defense for collaborations with Heven Drones and Stedicopter after 
      full integration with their platforms. 

Ariel Alon, CEO of ParaZero, commented: "As the newly appointed CEO of ParaZero Technologies, I am thrilled to lead a company with such immense potential in the rapidly growing counter-drone and defense markets. We believe that our recent successes, including securing approvals from DECA under the Israeli Ministry of Defense for the global marketing of our DefendAir counter-UAS system and achieving a 100% interception rate in live field demonstrations, position us well at the forefront of a market projected to grow from USD 3.10 billion in 2025 to USD 12.24 billion by 2032, with a CAGR of 21.62%. Our advancements in precision airdrop systems like DropAir, coupled with our strategic partnerships, demonstrate our capability to deliver cutting-edge solutions. I see tremendous potential opportunities to drive innovation and capture market share in this dynamic, high-growth sector."

First Half 2025 Financial Highlights:

   -- Sales totaled to $357,979 for the six months ended June 30, 2025, 
      compared to $282,693 for the six months ended June 30, 2024. This 
      increase was mainly attributed to the company shifting towards sales of 
      newly developed products, mainly in the defense sector, and original 
      equipment manufacturer integrations that contributed to a higher volume 
      of sales rather than to the aftermarket segment. 
 
   -- Cost of sales amounted to $431,888 for the six months ended June 30, 
      2025, compared to $209,529 for the six months ended June 30, 2024. The 
      increase was mainly due to the increase in the volume of sales and 
      product mix during the six months ended June 30, 2025, an inventory 
      write-off and higher overhead costs and personnel related to the new 
      lease for our corporate offices and headquarters. 
 
   -- Research and development expenses for the six months ended June 30, 2025, 
      amounted to $1,155,436, compared to $662,440 for the six months ended 
      June 30, 2024. The increase resulted mainly from labor costs due to the 
      increased number of employees and contractors' costs. 
 
   -- Selling and marketing expenses totaled $752,420 for the six months ended 
      June 30, 2025, compared to $516,401 for the six months ended June 30, 
      2024. The increase resulted mainly from labor costs and marketing 
      services, accompanied by an increase in travel and conferences 
      participation costs. 
 
   -- General and administrative expenses totaled $1,670,513 for the six months 
      ended June 30, 2025, compared to $1,122,759 for the six months ended June 
      30, 2024. The increase resulted mainly from non-cash expenses related to 
      grants pursuant to our equity incentive plan and certain filing services. 
 
   -- Comprehensive and net loss amounted to $2,295,955 for the six months 
      ended June 30, 2025, compared to a net loss of $2,026,094 for the six 
      months ended June 30, 2024. The increase was the result of changes in 
      fair value of derivative warrant liabilities, along with an increase in 
      expenses related to grants pursuant to our equity incentive plan along 
      with an increase of operating expenses, as described above. 
 
   -- Net loss per share for the six months of 2025 was $0.14 compared to net 
      loss per share of $0.19 for the six months ended June 30, 2024. 
 
   -- As of June 30, 2025, the Company's cash, cash equivalents and short-term 
      deposits were $4.86 million and approximately $6.2 million  as of August 
      27, 2025. 

About ParaZero Technologies

ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a recognized leader in advanced drone technologies, supporting commercial, industrial, and governmental operations worldwide. The company's product portfolio includes SafeAir, an autonomous parachute recovery system designed for aerial safety and regulatory compliance; DefendAir, a counter-UAS net-launching platform for protection against hostile drones in both battlefield and urban environments; and DropAir, a precision aerial delivery system. ParaZero's mission is to redefine the boundaries of aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security. For more information, visit https://parazero.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, ParaZero is using forward-looking statements when it discusses the potential of the company, the rapidly growing counter-drone and defense markets, it belief that its recent successes position it to be at the forefront of the growth in the global anti-drone market and its potential opportunities to drive innovation and capture market share. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ("SEC"), including, but not limited to, the risks detailed in the Company's Annual Report on Form 20-F filed with the SEC on March 21, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites.

Investor Relations Contact:

Michal Efraty

Investor Relations

michal@efraty.com

 
                    ParaZero Technologies Ltd. 
                           BALANCE SHEET 
         (U.S. dollars in thousands, except share data and 
                          per share data) 
------------------------------------------------------------------ 
 
                                         June 30,   December 31, 
                                   Note    2025         2024 
                                   ----  ---------  ------------ 
   ASSETS 
 
CURRENT ASSETS: 
   Cash and cash equivalents             2,365,582     4,178,866 
   Short term deposits                   2,500,000            -- 
   Trade receivables                        36,675       114,564 
   Other current assets               3    550,044       421,919 
   Inventories                             340,461       394,193 
                                         ---------  ------------ 
 
TOTAL CURRENT ASSETS                     5,792,762     5,109,542 
                                         ---------  ------------ 
 
NON-CURRENT ASSETS: 
   Restricted deposit                 4     76,364        68,001 
   Prepaid expenses                         15,728        33,333 
   Operating lease right-of-use 
    asset                             5    332,449       418,790 
   Property and equipment, net             114,962       107,906 
                                         ---------  ------------ 
TOTAL NON-CURRENT ASSETS                   539,503       628,030 
                                         ---------  ------------ 
 
TOTAL ASSETS                             6,332,265     5,737,572 
                                         =========  ============ 
 
 
 
               LIABILITIES AND SHAREHOLDERS' EQUITY 
         (U.S. dollars in thousands, except share data and 
                          per share data) 
------------------------------------------------------------------ 
 
                                      June 30,     December 31, 
                               Note     2025           2024 
                               ----  -----------   ------------ 
   LIABILITIES AND 
   SHAREHOLDERS' EQUITY 
 
CURRENT LIABILITIES: 
   Trade payables                        182,322        184,247 
   Operating lease 
    liabilities                   5      218,985        202,563 
   Other current liabilities      6      835,830        933,995 
                                     -----------   ------------ 
 
TOTAL CURRENT LIABILITIES              1,237,137      1,320,805 
                                     -----------   ------------ 
 
NON-CURRENT LIABILITIES: 
 
   Operating lease 
    liabilities, net of 
    current portion               5      141,169        216,917 
   Derivative warrant 
    liabilities                   7    1,424,033      4,511,491 
                                     -----------   ------------ 
 
TOTAL NON-CURRENT LIABILITIES          1,565,202      4,728,408 
                                     -----------   ------------ 
 
COMMITMENTS AND CONTINGENCIES     9 
 
SHAREHOLDERS' DEFICIT             8 
   Ordinary shares, NIS 0.02 
    par value: Authorized 
    200,000,000 as of June 
    30, 2025 and December 31, 
    2024; Issued and 
    outstanding 17,063,630 
    and 12,817,092 shares as 
    of June 30, 2025 and as 
    of December 31, 2024, 
    respectively                          95,782         72,061 
   Additional paid-in capital         35,207,386     29,093,585 
   Accumulated losses                (31,773,242)   (29,477,287) 
                                     -----------   ------------ 
 
TOTAL SHAREHOLDERS' EQUITY             3,529,926       (311,641) 
                                     -----------   ------------ 
 
TOTAL LIABILITIES AND 
 SHAREHOLDERS' EQUITY                  6,332,265      5,737,572 
                                     ===========   ============ 
 
 
 
                  STATEMENTS OF COMPREHENSIVE LOSS 
          (U.S. dollars in thousands, except share data and 
                           per share data) 
-------------------------------------------------------------------- 
 
                             Six months ended    Six months ended 
                                  June 30,           June 30, 
                                   2025                2024 
                             -----------------   ---------------- 
                                         U.S. dollars 
                             ------------------------------------ 
 
Sales                                  357,979            282,693 
Cost of Sales                          431,888            209,529 
                              ----------------   ---------------- 
 
GROSS PROFIT (LOSS)                    (73,909)            73,164 
 
   Research and development 
    expenses                         1,155,436            662,440 
   Selling and marketing 
    expenses                           752,420            516,401 
   General and 
    administrative expenses          1,670,513          1,122,759 
                              ----------------   ---------------- 
 
OPERATING LOSS                      (3,652,278)        (2,228,436) 
Change in fair value of 
 derivative warrant 
 liabilities                         1,253,042             67,227 
Other finance income, net              103,281            135,115 
                              ================   ================ 
 
NET LOSS AND COMPREHENSIVE 
 LOSS                               (2,295,955)        (2,026,094) 
                              ================   ================ 
 
Net loss per ordinary share, 
 basic and diluted                       (0.14)             (0.19) 
                              ================   ================ 
Weighted average number of 
 ordinary shares 
 outstanding, basic and 
 diluted                            16,018,334         10,940,958 
                              ================   ================ 
 
 
 
             STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) 
                (U.S. dollars in thousands, except share data and 
                                 per share data) 
--------------------------------------------------------------------------------- 
 
                      Ordinary shares    Additional 
                    ------------------- 
                      Number              paid-in     Accumulated 
                     of shares   Amount   capital       losses        Total 
                    -----------  ------  ----------   -----------   ---------- 
 
BALANCE AS OF 
 DECEMBER 31, 2023   10,073,956  56,227  24,471,888   (18,423,057)   6,105,058 
CHANGES DURING 
THE SIX MONTHS 
ENDED JUNE 30, 
2024: 
   Stock based 
    compensation              -       -      26,434             -       26,434 
   Exercise of 
    pre-funded 
    warrants and 
    consultant 
    warrants (Note 
    8B)               1,088,590   5,792      (5,792)            -            - 
   Comprehensive 
    loss                      -       -           -    (2,026,094)  (2,026,094) 
                     ----------  ------  ----------   -----------   ---------- 
 
BALANCE AS OF JUNE 
 30, 2024            11,162,546  62,019  24,492,530   (20,449,151)   4,105,398 
                     ==========  ======  ==========   ===========   ========== 
 
BALANCE AS OF 
 DECEMBER 31, 2024   12,817,092  72,061  29,093,585   (29,477,287)    (311,641) 
CHANGES DURING 
SIX MONTHS ENDED 
JUNE 30, 2025: 
   Issuance of 
    ordinary shares 
    and pre-funded 
    warrants, net 
    of issuance 
    costs (Note 
    8D)               2,818,182  15,762   2,516,733                  2,532,495 
   Stock based 
    compensation                            511,818                    511,818 
   Issuance of 
    ordinary shares 
    from vested 
    restricted 
    share units         283,999   1,611      (1,611)                         - 
   Exercise of 
    series A 
    warrants (Note 
    8B)               1,144,357   6,348   3,086,861                  3,093,209 
   Comprehensive 
    loss                                               (2,295,955)  (2,295,955) 
                     ----------  ------  ----------   -----------   ---------- 
 
BALANCE AS OF JUNE 
 30, 2025            17,063,630  95,782  35,207,386   (31,773,242)   3,529,926 
                     ==========  ======  ==========   ===========   ========== 
 
 
 
                      STATEMENTS OF CASH FLOWS 
          (U.S. dollars in thousands, except share data and 
                           per share data) 
-------------------------------------------------------------------- 
 
                                             Six months ended 
                                                 June 30, 
                                         ------------------------ 
                                            2025          2024 
                                         -----------   ---------- 
CASH FLOWS FROM OPERATING ACTIVITIES: 
Net loss                                  (2,295,955)  (2,026,094) 
 
Adjustments required to reconcile net 
loss to net cash used in operating 
activities: 
 
Depreciation                                  13,762       10,448 
Stock based compensation                     511,818       26,434 
Inventory write-down                          81,677           -- 
Changes in fair value of derivative 
 liabilities                              (1,253,042)     (67,227) 
Loss from exchange differences on cash 
 and cash equivalents                          5,640        2,850 
Finance (expenses) income                     27,015      (14,104) 
Changes in operating assets and 
liabilities: 
Trade receivables, net                        77,889      (89,622) 
Other current assets                        (128,125)     (34,221) 
Prepaid expenses                              17,605           -- 
Inventories                                  (27,945)    (113,261) 
Operating lease right-of use asset            86,341       53,863 
Trade payables                                (1,925)     134,346 
Operating lease liabilities                  (86,341)     (53,279) 
Other current liabilities                    (98,165)     166,386 
                                          ----------   ---------- 
 
Net cash used in operating activities     (3,069,751)  (2,003,481) 
                                          ----------   ---------- 
 
CASH FLOWS FROM INVESTING ACTIVITIES: 
 
Investment in short term deposits         (2,500,000)          -- 
Change in restricted deposit                  (8,363)     (68,603) 
Purchase of property and equipment           (20,818)     (64,366) 
                                          ----------   ---------- 
Net cash used in investing activities     (2,529,181)    (132,969) 
                                          ----------   ---------- 
CASH FLOWS FROM FINANCING ACTIVITIES: 
 
Proceeds from exercise of series A 
warrants (Note 8B)                         1,258,793           -- 
Issuance of ordinary shares and 
prefunded warrants, net of issuance 
costs (Note 8D)                            2,532,495           -- 
                                          ----------   ---------- 
Net cash from financing activities         3,791,288           -- 
                                          ----------   ---------- 
 
Effect of exchange rate changes on cash, 
 cash equivalents                             (5,640)      (2,850) 
Net decrease in cash and cash 
 equivalents                              (1,813,284)  (2,139,300) 
Cash and cash equivalents at beginning 
 of period                                 4,178,866    7,428,405 
                                          ----------   ---------- 
Cash and cash equivalents at end of 
 period                                    2,365,582    5,289,105 
                                          ==========   ========== 
 

(END) Dow Jones Newswires

August 28, 2025 16:15 ET (20:15 GMT)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10